Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.

So how do we know what these investors just did? Today, Benzinga's options scanner spotted 9 uncommon options trades for DexCom. This isn't normal. The overall sentiment of these big-money traders ...

In December 2023, Dexcom announced the Dexcom G7 CGM System connectivity with the t: slim X2 insulin pump by Tandem Diabetes Care in the United States, marking the first AID integration with the ...

Today, Benzinga's options scanner spotted 9 options trades for DexCom. This isn't normal. The overall sentiment of these big-money traders is split between 66% bullish and 22%, bearish.

DexCom received a warning letter from the Food ... The diabetes devices maker on Friday said the warning letter doesn't restrict its ability to produce, market, manufacture or distribute products.